Hepatic alpha-adrenergic receptors. Identification and subcellular localization using [3H]dihydroergocryptine

Area of Science:

• Biochemistry
• Pharmacology
• Cell Biology

Background:

• Adrenergic control of hepatic carbohydrate metabolism is increasingly recognized as alpha-receptor-mediated.
• Previous research suggests a significant role for alpha-adrenergic signaling in liver function.

Purpose of the Study:

• To identify and characterize alpha-adrenergic receptors in rat liver membranes.
• To determine the subcellular localization of these alpha-adrenergic receptors.

Main Methods:

• Utilized rat liver membrane preparations for receptor binding assays with [3H]dihydroergocryptine.
• Performed Scatchard analysis to determine receptor affinity (KD) and density.
• Fractionated liver tissue and measured specific dihydroergocryptine binding, (Na,K)-ATPase, and adenylate cyclase activity to assess subcellular localization.

Main Results:

• Alpha-adrenergic receptors were identified as saturable and high-affinity binding sites for [3H]dihydroergocryptine.
• Pharmacological profiling confirmed typical alpha-adrenergic receptor binding affinities, with phentolamine being a potent blocker.
• Specific binding activity was significantly enriched in plasma membrane fractions compared to crude homogenates.

Conclusions:

• Hepatic alpha-adrenergic receptors exhibit characteristics consistent with plasma membrane localization.
• The findings support the concentration of alpha-adrenergic receptors in the plasma membrane, playing a key role in hepatic function.